Literature DB >> 1165961

"Streaking leukocyte factor," arthritis, and pyoderma gangrenosum.

J C Jacobs, E J Goetzl.   

Abstract

A 14-year-old boy with a 12-year history of episodes of sterile pyarthrosis and cutaneous inflammation and ulceration was found to possess a serum factor which enhanced the random migration of leukocytes in vitro. The serum factor was isolated by Sephadex G-200 gel filtration and found to have a molecular weight of approximately 160,000. This partially purified principle enhanced the random migration of purified normal human neutrophils or mononuclear leukocytes by up to 200% without influencing chemotaxis. Trauma or other stimuli may lead to an accumulation of this serum factor in some tissues of the patient with resultant excessive leukocyte influx and heightened local activity of the leukocytes in the inflammatory exudate.

Entities:  

Mesh:

Year:  1975        PMID: 1165961

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

1.  Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.

Authors:  K Abu-Elmagd; B V Jegasothy; C D Ackerman; A W Thomson; H Rilo; N Nikolaidis; D Van Thiel; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts.

Authors:  W Löffler; P Lohse; T Weihmayr; W Widenmayer
Journal:  Infection       Date:  2017-03-01       Impact factor: 3.553

Review 3.  Autoinflammation: From monogenic syndromes to common skin diseases.

Authors:  Tien V Nguyen; Edward W Cowen; Kieron S Leslie
Journal:  J Am Acad Dermatol       Date:  2013-02-28       Impact factor: 11.527

4.  Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression.

Authors:  P C van de Kerkhof; G A de Vaan; R Holland
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

Review 6.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

7.  Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q.

Authors:  H B Yeon; N M Lindor; J G Seidman; C E Seidman
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

8.  Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).

Authors:  K Abu-Elmagd; D H Van Thiel; B V Jegasothy; J C Jacobs; P Carroll; H Rodriquez-Rilo; C D Ackerman; J J Fung; T E Starzl
Journal:  Ann Intern Med       Date:  1993-10-01       Impact factor: 25.391

9.  Neutrophil function in systemic lupus erythematosus and other collagen diseases.

Authors:  H Al-Hadithy; D A Isenberg; I E Addison; A H Goldstone; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

10.  Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.

Authors:  R R Jones; A Kobza Black; M Donaghy; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.